Pages
Products
Synapsin-Null Lentivirus

Synapsin-Null Lentivirus

Cat.No. :  LV00957Z

Titer: ≥1*10^7 TU/mL / ≥1*10^8 TU/mL / ≥1*10^9 TU/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Lentivirus Particle Information

Quality Control

Cat. No. LV00957Z
Description This lentivirus contains no insert gene under the control of human Synapsin promoter and can be used for negative control.
Target Gene Empty
Titer Varies lot by lot, for example, ≥1*10^7 TU/mL, ≥1*10^8 TU/mL, ≥1*10^9 TU/mL etc.
Size Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

Lentiviruses (LVs) are produced as replication-defective viral particles whose RNA genome contains a so-called self-inactivating (SIN) 3′ long terminal repeat (LTR) that, after reverse transcription into a linear double-stranded DNA genome, produces a U3-deleted, enhancer- and promoter-less 5′ long terminal repeat (LTR). The ΔU3 long terminal repeat retains the minimum 18 bp long HIV-1 sequence required for integration, as well as the R region and the U5 region containing the polyadenylation sequence of the vector. Thus, the SIN lentiviral provirus is transcriptionally inactive, allowing the vector to carry a completely independent transgene expression cassette. In addition, the lentiviral genome retains the cis-acting viral sequences required for viral encapsidation, reverse transcription, and integration in the host cell genome, and lacks all other viral regulatory elements and genes, which are replaced by the transgene vector. These essential sequences include the packaging signal (Ψ), the primer binding site (PBS) and polypurine sequence (PPT) required for reverse transcription, the major HIV-1 intron with donor and acceptor splice sites, and the Rev response element (RRE) required for Rev-mediated nuclear export of the unspliced ​​intact genomic transcript. During the packaging process, two copies of the genomic transcript are selected from the cellular RNA pool through the interaction of the Ψ sequence located in the 5′ untranslated region with the Gag nucleocapsid domain. The lentiviral Ψ is a complex sequence that includes part of the transcriptional activation response element (TAR) of the U5 region, the PBS, and part of the gag gene, all of which are required for efficient packaging. The binding of Rev to the RRE enhances encapsidation by 70-fold, so its incorporation into the lentivirus (LV) is also required for packaging. Overall, the size of the complete LV Ψ is approximately 1.7 kb; attempts to remove or shorten its components result in reduced viral titers.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Highly recommend it!

This product performs very accurately in experiments and provides us with reliable data support. It is worth recommending.

Germany

06/01/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction